Nocturnal rise in markers of bone resorption is not abolished by bedtime calcium or calcitonin

1994 ◽  
Vol 55 (5) ◽  
pp. 349-352 ◽  
Author(s):  
S. Sairanen ◽  
R. T�htel� ◽  
K. Laitinen ◽  
S. L. Karonen ◽  
M. J. V�lim�ki
Keyword(s):  
Bone Resorption ◽  
Markers Of Bone Resorption ◽  
Nocturnal Rise

Markers of bone resorption in patients treated with pamidronate

Bone ◽  
1995 ◽  
Vol 17 (6) ◽  
pp. 615 ◽  
Author(s):  
A. Lipton ◽  
L. Demers ◽  
E. Curley ◽  
V. Chinchili ◽  
L. Gaydos ◽  
...  
Keyword(s):  
Bone Resorption ◽  
Markers Of Bone Resorption

New biochemical markers of bone resorption in the study of postmenopausal osteoporosis

1997 ◽  
Vol 265 (2) ◽  
pp. 225-234 ◽  
Author(s):  
Concepción de la Piedra ◽  
Maria Luisa Traba ◽  
Casimira Dominguez Cabrera ◽  
Manuel Sosa Henríquez
Keyword(s):  
Bone Resorption ◽  
Postmenopausal Osteoporosis ◽  
Biochemical Markers ◽  
Markers Of Bone Resorption

Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget disease

1995 ◽  
Vol 41 (11) ◽  
pp. 1592-1598 ◽  
Author(s):  
A Blumsohn ◽  
K E Naylor ◽  
A M Assiri ◽  
R Eastell
Keyword(s):  
Bone Resorption ◽  
Biochemical Markers ◽  
Type I Collagen ◽  
Bisphosphonate Therapy ◽  
Response To Therapy ◽  
Tartrate Resistant Acid Phosphatase ◽  
Type I ◽  
Paget Disease ◽  
Markers Of Bone Resorption ◽  
Total Alkaline

Abstract We examined the response of different biochemical markers of bone resorption to bisphosphonate therapy (400 mg of etidronate daily for 6 months) in mild Paget disease (n = 14). Urinary markers included hydroxyproline (OHP), total (T) and free (F) pyridinolines (Pyds) determined by HPLC, immunoreactive FPyds, immunoreactive TPyds, and the N- and C-terminal telopeptides of type I collage (NTx, CL). Serum measurements included tartrate-resistant acid phosphatase (TRAcP) and the C-terminal telopeptide of type I collagen (ICTP). ICTP and TRAcP showed a minimal response to therapy (% change at 6 months, -13.1 +/- 6.8 and -6.7 +/- 3.4, respectively). The response was greatest for urinary telopeptides (NTx and CL; % change -75.7 +/- 7.5 and -73.4 +/- 8.9, respectively). The response was somewhat greater for TPyds than for FPyds. We conclude that: (a) ICTP and TRAcP are unreliable indicators of changes in bone turnover; (b) oligopeptide-bound Pyds and telopeptide fragments of type I collagen in urine show a somewhat greater response to therapy than do FPyds and may be more sensitive indicators of bone resorption; and (c) as yet no evidence suggests that these markers are substantially better predictors of the clinical response to therapy than serum total alkaline phosphatase or urinary OHP. There are several problems with the interpretation of these measurements in Paget disease, and the clinical utility of these measurements remains uncertain.

scholarly journals Interferon Gamma‐1b Does Not Increase Markers of Bone Resorption in Autosomal Dominant Osteopetrosis

2019 ◽  
Vol 34 (8) ◽  
pp. 1436-1445 ◽  
Author(s):  
Erik A Imel ◽  
Ziyue Liu ◽  
Dena Acton ◽  
Melissa Coffman ◽  
Netsanet Gebregziabher ◽  
...  
Keyword(s):  
Bone Resorption ◽  
Interferon Gamma ◽  
Autosomal Dominant ◽  
Markers Of Bone Resorption ◽  
Autosomal Dominant Osteopetrosis

13. Validation of collagen crosslinks as markers of bone resorption: comparison with radioisotopic method

Bone ◽  
1991 ◽  
Vol 12 (4) ◽  
pp. 289-290
Author(s):  
R. Eastell ◽  
L. Hampton ◽  
A. Colwell ◽  
J.R. Green ◽  
A.M.A. Assiri ◽  
...  
Keyword(s):  
Bone Resorption ◽  
Collagen Crosslinks ◽  
Radioisotopic Method ◽  
Markers Of Bone Resorption
Sign in / Sign up

Export Citation Format

Share Document